Q2 2026 13F · SEC CIK 1769456

Invenomic Capital Management LP

Mutual fund managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $1.7B
Reported positions: 115
Top holdings a year, 3 yrs: +8.5%
Assets under management: $3.4B

Invenomic Capital Management LP is a mutual fund manager that reported 115 positions worth $1.7B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Global Pmts Inc (GPN, 3.8%), Universal Hlth Svcs Inc (UHS, 3.8%), Workday Inc Cl A (WDAY, 3.5%). A portfolio copying its top holdings returned 8.5% a year over the last 3 years, against 20.4% for the S&P 500.

Invenomic Capital Management LP holdings largest 50 of 115 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Invenomic Capital Management LP 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
GPNGlobal Pmts Inc	3.8%	2.8%	881,579	-3.6%	$64.0M
UHSUniversal Hlth Svcs Inc	3.8%	1.5%	427,264	+130.8%	$63.5M
WDAYWorkday Inc Cl A	3.5%	3.4%	476,106	-15.0%	$58.3M
XRAYDentsply Sirona Inc	3.1%	2.4%	4,909,808	+11.8%	$52.1M
SPSCSps Comm Inc	3.0%	—	869,410	—	$49.7M
PVHPvh Corporation	2.6%	2.5%	575,346	-24.6%	$42.7M
BDXBecton Dickinson & Co	2.5%	—	273,182	—	$41.3M
FISFidelity Natl Information Sv	2.5%	2.2%	1,060,601	+2.6%	$41.2M
CHTRCharter Communications Inc	2.4%	—	282,416	—	$40.2M
EGOEldorado Gold Corp	2.1%	2.3%	1,157,819	-19.3%	$36.0M
OMCOmnicom Group Inc	2.1%	1.6%	479,221	+7.2%	$34.9M
LYFTLyft Inc	2.1%	1.8%	2,350,081	-19.7%	$34.3M
BILLBill Holdings Inc	2.0%	1.8%	908,775	-12.1%	$32.9M
CLVTClarivate PLC	1.8%	1.6%	14,261,471	+7.1%	$30.8M
CRMSalesforce Inc	1.8%	1.9%	193,300	-13.5%	$30.3M
INGMIngram Micro Hldg Corp	1.8%	1.5%	1,077,596	-21.9%	$29.6M
INTUIntuit	1.7%	—	106,609	—	$27.8M
VTRSViatris Inc	1.6%	2.0%	1,738,790	-46.2%	$27.6M
CNMDConmed Corp	1.6%	1.5%	842,162	-9.9%	$27.6M
OCOwens Corning New	1.5%	0.9%	160,637	-8.7%	$25.5M
FISVFiserv Inc	1.5%	1.6%	520,236	-16.8%	$25.5M
SONSonoco Prods Co	1.5%	1.1%	438,219	-0.3%	$24.7M
ABMAbm Inds Inc	1.4%	1.0%	532,082	-4.8%	$23.5M
NOMDNomad Foods Ltd	1.4%	0.9%	2,092,084	+6.9%	$22.9M
STSensata Technologies Hldg Pl	1.3%	1.5%	470,222	-50.5%	$22.4M
MNDYMonday Com Ltd	1.3%	—	290,707	—	$21.0M
INGRIngredion Inc	1.2%	1.4%	220,493	-15.4%	$20.9M
UPWKUpwork Inc	1.2%	1.0%	2,406,922	+25.7%	$20.1M
HURNHuron Consulting Group Inc	1.2%	—	220,073	—	$19.8M
DOLEDole PLC Ord Shs	1.2%	1.2%	1,430,966	-18.7%	$19.6M
PATHUipath Inc	1.2%	0.8%	1,787,590	+9.2%	$19.4M
FIVNFive9 Inc	1.1%	—	892,658	—	$19.0M
DLODlocal Ltd	1.1%	—	1,395,170	—	$18.1M
PRGSProgress Software Corp	1.0%	—	511,240	—	$17.2M
LZLegalzoom.com Inc	1.0%	0.8%	2,676,821	-8.5%	$16.4M
HAEHaemonetics Corp Mass	1.0%	1.7%	216,217	-67.5%	$16.2M
ENOVEnovis Corporation	1.0%	0.9%	772,034	-14.5%	$16.0M
TNCTennant Co	1.0%	1.1%	182,387	-47.8%	$16.0M
COURCoursera Inc	0.9%	1.0%	2,798,362	-21.2%	$15.8M
PENNPenn Entertainment Inc	0.9%	1.1%	738,495	-52.2%	$15.8M
CMCSAComcast Corp New	0.9%	—	629,808	—	$15.5M
ZBHZimmer Biomet Holdings Inc	0.9%	—	178,691	—	$15.4M
GENGen Digital Inc	0.9%	—	610,309	—	$15.2M
GEHCGe Healthcare Technologies I	0.9%	—	233,035	—	$14.9M
PRUPrudential Finl Inc	0.9%	—	135,381	—	$14.6M
KBRKbr Inc	0.8%	—	369,476	—	$12.8M
RYIRyerson Hldg Corp	0.7%	—	508,048	—	$12.5M
CHWYChewy Inc	0.7%	—	613,972	—	$12.1M
CXTCrane Nxt Co	0.7%	—	233,914	—	$12.0M
MDTMedtronic PLC	0.7%	—	152,330	—	$11.9M

What Invenomic Capital Management LP bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +21.4% /yr; S&P 500 +20.1%
3 years: +8.5% /yr; S&P 500 +20.4%
5 years: +9.7% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$1.7B	115
Q1 2026	$2.2B	148
Q4 2025	$2.1B	144
Q3 2025	$1.9B	141
Q2 2025	$1.8B	148
Q1 2025	$2.0B	168
Q4 2024	$1.8B	153
Q3 2024	$1.8B	141
Q2 2024	$1.9B	157
Q1 2024	$1.9B	145
Q4 2023	$1.9B	166
Q3 2023	$2.4B	145

Questions about Invenomic Capital Management LP's portfolio

What stocks does Invenomic Capital Management LP own?

Invenomic Capital Management LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 115 positions worth $1.7B. The largest are Global Pmts Inc (GPN) at 3.8%, Universal Hlth Svcs Inc (UHS) at 3.8%, Workday Inc Cl A (WDAY) at 3.5%, Dentsply Sirona Inc (XRAY) at 3.1% and Sps Comm Inc (SPSC) at 3.0%.

What did Invenomic Capital Management LP buy last quarter?

In Q2 2026, Invenomic Capital Management LP added Universal Hlth Svcs Inc (UHS) (+130.8% shares), Upwork Inc (UPWK) (+25.7% shares) and Dentsply Sirona Inc (XRAY) (+11.8% shares), compared with its Q1 2026 filing.

What did Invenomic Capital Management LP sell last quarter?

In Q2 2026, Invenomic Capital Management LP cut from its top 50 Chord Energy Corporation (CHRD), cut from its top 50 Teleflex Incorporated (TFX), cut from its top 50 Akamai Technologies Inc (AKAM), cut from its top 50 Wix Com Ltd (WIX), cut from its top 50 Ringcentral Inc (RNG), Haemonetics Corp Mass (HAE) (-67.5% shares), Penn Entertainment Inc (PENN) (-52.2% shares) and Sensata Technologies Hldg Pl (ST) (-50.5% shares), compared with its Q1 2026 filing.

How has Invenomic Capital Management LP's portfolio performed?

A portfolio copying Invenomic Capital Management LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +8.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.4% against +20.1%. Over 5 years: +9.7% a year against +11.6%.

When is Invenomic Capital Management LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Invenomic Capital Management LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Invenomic Capital Management LP manage?

Invenomic Capital Management LP reported $3.4B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $1.7B.